New technologies and treatments are a significant driver of skyrocketing health costs and the resulting overtreatment is harming our health. Join us for a webinar September 30th at 1pm with The New England Comparative Effectiveness Public Advisory Council (CEPAC) to learn more about comparative effectiveness research and how it is being evaluated and applied in New England. CEPAC is an initiative of the Institute for Clinical and Economic Review in Boston, funded by the US Agency for Healthcare Quality and Review. To make informed healthcare decisions policymakers, patients and clinicians need rigorous evidence on the comparative risks and benefits of care options. But that science must be integrated with patient values, individual clinical needs, costs, current patterns of practice, local health system characteristics and public values. CEPAC provides a forum to discuss all these considerations. CEPAC’s mission is to provide objective, independent guidance on how information from AHRQ evidence reviews can be used across New England to improve the quality and value of health care decision making. CEPAC includes clinicians, scientists, policymakers and patient advocates with members from all the New England states. Our first meeting was in June in Boston and focused on treatment strategies for atrial fibrillation.
Ellen Andrews